✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Survival was found to be prolonged in patients treated with surgical resection and combined chemotherapy on stage third.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Twenty five patients with advanced ovarian cancer were investigated according to stage, treatment modality and survival.
📊
Key Findings & Data:Twenty five patients with advanced ovarian cancer were investigated according to stage, treatment modality and survival.
💡
Conclusion & Impact:Survival was found to be prolonged in patients treated with surgical resection and combined chemotherapy on stage third.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Twenty five patients with advanced ovarian cancer were investigated according to stage, treatment modality and survival. Survival was found to be prolonged in patients treated with surgical resection and combined chemotherapy on stage third.
Özet
İleri evre over kanseri tanısı ile takip ve tedavi edilen 25 hasta, klinik evre, uygulanan tedavi ve takip süresi yönünden incelendi. III. Evre, cerrahi rezeksiyon yapılabilmesi ve kombine kemoterapi uygulamaları, iyi prognostik faktörler olarak bulundu.
🔖
Cite This Article
ÇETİN, M., MÜDERRİS, İ. İ., KARAHACIOĞLU, E., ÜNAL, A., ALTINBAŞ, M. (2022). Combination chemotherapies in advanced ovarian cancer. Erciyes Tıp Dergisi, Cilt: 17 - Sayı: 3, 271–274. https://ajindex.com/articles/503117